Retinitis Pigmentosa Syndrome
📧 Sign up to get email alerts when something new happens for Retinitis Pigmentosa Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2024-10-15Clinical Trial Update: Dose Escalation Study to Evaluate the Safety/Tolerability and Efficacy of EA-2353 in Subjects With Retinitis Pigmentosa [Phase 1, Phase 2]
A dose-escalation trial evaluating the safety, tolerability, and efficacy of EA-2353 in subjects with Retinitis Pigmentosa was terminated (P…